INOVIO PHARMACEUTICALS, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA, 19462
Mailing Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA, 19462
Phone
8584103134
Fiscal Year End
1231
EIN
330969592
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 424B5 Prospectus supplement | April 2, 2026 | View on SEC |
| 424B5 Prospectus supplement | April 2, 2026 | View on SEC |
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Positive interim Phase 2 data for lead oncology candidate INO-XXXX, potentially paving the way for a pivotal Phase 3 study.
- Secured a new research collaboration worth up to $50 million for a novel infectious disease vaccine.
Material Events
8-K
Financial Distress
March 12, 2026
High Impact
- FDA accepted Biologics License Application (BLA) for lead drug INO-3107 under Accelerated Approval program.
- A target decision date (PDUFA date) of October 30, 2026, has been set for INO-3107.
8-K
Other
December 29, 2025
High Impact
- The U.S. FDA has accepted INOVIO's Biologic License Application (BLA) for INO-3107, a drug to treat recurrent respiratory papillomatosis (RRP) in adults.
- The FDA expressed preliminary concern that INOVIO has not provided enough information to justify the requested accelerated approval pathway.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.